Navigation Links
MonoSol Rx and Midatech Group Enter Collaboration Agreement to Unite Nanoparticle and Thin Film Drug Delivery Technologies
Date:11/3/2008

gy for all PharmFilm(R) products is to partner with the innovator or other specialty pharma or leading consumer products companies who have the core competency to sell-in and manage the sales and marketing of the products. For the Company's existing and future partners, PharmFilm(R) formulations represent revenue-life cycle extensions for products with patent lives that have expired or are approaching expiration. PharmFilm(R) is also a tool to help sales and marketing partners differentiate in competitive markets while offering unique advantages over drugs dosed by traditional tablets, capsules and ODTs.

About Midatech Group

Midatech Group Ltd is a world leader in the design, synthesis and manufacture of biocompatible nanoparticles. These nanoparticles can be used to create a wide variety of products with novel characteristics, functions and applications that have the potential for multiple diagnostic and therapeutic applications.

Created in 2000, Midatech has IP covering design, manufacture and application/use of nanoparticles in both diagnostic and therapeutic pharmaceutical areas. As well as in-house product development, it is prepared to licence this IP to 3rd Party pharmaceutical and diagnostic development partners whilst retaining manufacturing rights. Midatech has exclusive world-wide rights for technology relating to the synthesis and applications of self-assembling nanoparticles. The Company opened a cGMP standard design and manufacturing plant for nanocells -- Midatech Biogune -- in Bilbao, Spain in 2007.
Contacts:

MonoSol Rx:

Keith Kendall

Chief Financial Officer

(732) 564-5000

The Ruth Group (on behalf of MonoSol Rx)

Jason Rando (media)

646-536-7025

jrando@theruthgroup.com

Stephanie Carrington / Sara Ephraim (investors)

646.536.7017/7002

scarrington@theruthgroup.com
'/>"/>

SOURCE MonoSol Rx
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process
2. Wall Street Journal Highlights Blood Management, Strategic Healthcare Group LLC, and Dr. Timothy Hannon
3. From Race Cars and Google Doodles to Day Spas and Night Lights: Groups Across the U.S. Prepare to Join World Diabetes Day Celebrations on November 14
4. AMERIGROUP Corporation Named One of Best Places to Work in Healthcare
5. BioTrends Research Group, Inc. Recognized as One of Philadelphias Fastest Growing Privately Held Companies
6. Jerome Wilson Joins PRA Internationals Late Phase Service Group
7. Balan Biomedical, Inc. Announces the Formation of Battery Consulting Group
8. Gerson Lehrman Group and BIO Collaborate to Identify Scientific Expertise for the Seventh Annual BIO Investor Forum
9. China Pharma Holdings, Inc. Appoints The Ruth Group
10. Simcere Pharmaceutical Group to Announce Third Quarter 2008 Earnings on Thursday, November 6, 2008
11. iMedica Partners With LDM GROUP to Offer ScriptGuide to Physician Practice Customers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 21, 2015 Research and Markets ( ... "Global Bioinformatics Market Outlook 2019" report to their ... mark of around US$ 3.7 Billion in 2013 with ... around 19% during 2015-2019 The report is ... of global developments and opportunities listed in the section ...
(Date:4/21/2015)... 21, 2015 Research and Markets ... the "Complete 2015-16 Induced Pluripotent Stem Cell ... Stem cell research and experimentation have ... as stem cells have the unique ability to ... nature allows them to differentiate into a wide ...
(Date:4/21/2015)... , April 21, 2015 The ... $313.0 million in 2014 to $605.1 million by 2019, at ... Browse through the TOC of ... analysis of the industry trends and segments, with help ... Early buyers will receive 10% ...
(Date:4/21/2015)... Contract Research Organization XenoTech, LLC , a division of ... ft2 facility. The planned move will double the size ... St. in Lenexa, KS. The new facility, boasting nearly ... remain in the Kansas City metro area, just blocks away ... ago. Remaining in the Kansas City area maintains the ...
Breaking Biology Technology:Global Bioinformatics Market Outlook Report 2014-2019 - The US$ 3.7 Billion Market is Expected to Grow at a CAGR of 19% during 2015-2019 2Global Bioinformatics Market Outlook Report 2014-2019 - The US$ 3.7 Billion Market is Expected to Grow at a CAGR of 19% during 2015-2019 3Global Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report 2North America Biostimulants Market is Expected to Reach $605.1 Million by 2019, at a CAGR of 14.1% From 2014 to 2019 2North America Biostimulants Market is Expected to Reach $605.1 Million by 2019, at a CAGR of 14.1% From 2014 to 2019 3XenoTech Plans Expansion to New Global Headquarters after Impressive Revenue Growth in 2014 2XenoTech Plans Expansion to New Global Headquarters after Impressive Revenue Growth in 2014 3
... 7 Monogram,Biosciences, Inc. (Nasdaq: MGRM ) announced ... to present a corporate overview at the,ThinkEquity Partners, G5: ... p.m. Eastern Time (10:30 a.m. Pacific Time) at the ... the live audio broadcast or the subsequent archived,recording, log ...
... and Risk ... Distant Sites, REHOVOT, Israel and NEW YORK, September 7 ... in the field of,microRNA and RNAi, announced today it will ... significant potential of microRNA,profiles to develop a diagnostic test for ...
... 5:30-7:30 p.m. (ET), SAN DIEGO, Sept. 7 ... developing products for,minimally disruptive surgical treatments for the spine, ... institutional investors and,analysts at the Waldorf=Astoria Hotel in New ... to 7:30 p.m. ET. The reception will be ...
Cached Biology Technology:Monogram Biosciences to Present at the ThinkEquity Partners' Fifth Annual Growth Conference 2NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma 2NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma 3NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma 4NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma 5NuVasive to Host Investor Reception on September 11, 2007 2NuVasive to Host Investor Reception on September 11, 2007 3NuVasive to Host Investor Reception on September 11, 2007 4
(Date:4/1/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market, announces the second shipment of a ... early access pre-order customers. Feedback from ... including Walmart, Target, AT&T, Dunkin, Donuts, Stop & Shop ... all outlets and very easy to use. Several users ...
(Date:3/30/2015)... and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) has announced ... in Automotive Sector 2014-2018" report to their offering. ... market in Automotive Sector to grow at a CAGR ... recognition is the ability of a device to identify ... recognition technology can be 2D-based or 3D-based. It uses ...
(Date:3/24/2015)... March 24, 2015   NexID Biometrics LLC, ... security-authentication needs, today announced the beginning of shipments of ... The company, based in Potsdam, ... three-day Connect:ID Expo, which began here today at the ... version 2.0 of its SDK boosts the accuracy rate ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2
... United States and Europe has identified a single genetic mutation ... with and without diabetes. Albuminuria is a condition caused by ... is an indication of kidney disease. The research team, ... association studies to identify missense variant (I2984V) in the CUBN ...
... tiniest pollution particles which we take in with ... people more vulnerable to cardiovascular and respiratory problems. While ... showing exactly how it does so has been challenging. ... Environmental Health Perspectives , scientists showed that in ...
... an estimated 10,000 shipping containers fall off container ships at ... for months, most eventually sink to the seafloor. No one ... deep seafloor. From March 8 to March 10, 2011, ... National Marine Sanctuary (MBNMS) will use a robotic submarine to ...
Cached Biology News:Gene variant influences chronic kidney disease risk 2Pinpointing air pollution's effects on the heart 2Pinpointing air pollution's effects on the heart 3MBARI and Monterey Bay National Marine Sanctuary to study effects of shipping containers lost at sea 2MBARI and Monterey Bay National Marine Sanctuary to study effects of shipping containers lost at sea 3
Recombinant Mouse Noggin...
PEG 8000 is used in the precipitation of phage, isolation of plasmid DNA and the enhancement of blunt-ended ligation reactions....
Human VASA Biotinylated Affinity Purified PAb...
Mouse Iduronate 2-Sulfatase Affinity Purified Polyclonal Ab Keywords: Sulfatases, Iduronate 2-Sulfatase, Mucopolysaccharidosis, Hunter Syndrome, Glycobiology Protein Family: Proteoglycan Regu...
Biology Products: